EMIS Projected Dividend Yield
Emisphere Technologies, Inc. ( NASDAQ : EMIS )Emisphere Technologies is a commercial stage pharmaceutical and drug delivery company. Co. is in partnership with pharmaceutical companies to develop new oral formulations of existing injectable bio-pharmaceutical products, as well as new chemical entities, using its Eligen® Technology. Co. launched its prescription medical food product, oral Eligen B12™ in the U.S. Beyond Eligen B12™, Co. utilizes its proprietary Eligen® Technology to create new oral formulations of therapeutic agents. Co.'s product pipeline includes prescription drug and medical food product candidates that are being developed in partnership or internally. 22 YEAR PERFORMANCE RESULTS |
|
EMIS Dividend History Detail EMIS Dividend News EMIS Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |


